The Long-Term Prognosis of PrEP

Video

HIV Stakeholders weigh on the future of PrEP.

Video Highlights

1:11 Gary Spinner, DMSc, PA, MPH, AAHIVS

3:46 Randy Matthews, PhD, MD

4:52 Carl Schmid

Welcome to our series, 1 Big Question, which asks 1 question to the medical community and we get their feedback on an important infectious disease topic.

In this episode, our 1 Big Question is: Will PrEP have a prominent role and significant impact in HIV prevention?

We interviewed Gary Spinner, DMSc, PA, MPH, AAHIVS, medical director of the HIV/AIDS Program, Southwest Community Health Center, Randy Matthews, PhD, MD, senior principal scientist, Merck, and Carl Schmid, executive director, HIV+Hepatitis Policy Institute.

Check out our video to hear their insights.

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.